Kavi Asset Management’s Pfizer PFE Stock Holding History

Kavi Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-130,591	Closed	-$4.01M	–	42
2015 Q4	$4.01M	Buy	+130,591	New	+$4.11M	3.3%	11

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Kavi Asset Management's PFE Position: Q1 2016 in Review

Kavi Asset Management sold out of Pfizer (PFE) in Q1 2016, closing a stake of 130,591 shares — an estimated $4.01M sold.

Kavi Asset Management first reported a position in PFE in Q4 2015 and held it in 1 quarter. The position peaked at $4.01M in Q4 2015. 1,969 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

Kavi Asset Management reported no remaining Pfizer position as of Q1 2016 after selling out during the quarter.
Kavi Asset Management sold 130,591 Pfizer shares in Q1 2016, an estimated $4.01M.
Kavi Asset Management first reported a position in Pfizer in Q4 2015 and held it in 1 quarter.
Kavi Asset Management's Pfizer position peaked at $4.01M in Q4 2015.
1,969 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Kavi Asset Management's 13F filing for Q1 2016, filed 13 May 2016.